29.09.10 00:09 Age: -23 Tage
International Events > Pharmaceuticals / Medical devices
Köln, 29.09.2010
7th FORUM Conference on Marketing Authorisation
Day 1: EU & Global Challenges - Variations, Paediatrics, Bioequivalence & Global Regulatory Compliance
- Variations Regulation
- Paediatrics & the new SmPC-guideline
- Bioequivalence Guideline
- Global quality & regulatory compliance
Your Speakers:
-
Susana Almeida
-

Grupo Tecnimede, PORTUGAL
Close
-
Markus Ambrosius
-

Sträter Law Firm, GERMANY
Link: www.KanzleiStraeter.de
Close
-
Dr. Peter Bachmann
-

Federal Institute for Drugs and Medical
Devices (BfArM), Bonn, GERMANY
Close
-
Malcolm Dash
-

Medicines and Healthcare Products
Regulatory Agency (MRHA),
London, THE UNITED KINGDOM
Close
-
Dr. Ulrich Granzer
-

Granzer Regulatory Consulting & Services, Munich, GERMANY
Link: www.granzer.biz
Close
-
Prof. Dr. Viveca Lena Odlind
-

Medical Products Agency (MPA),
Uppsala, SWEDEN
Close
-
Dr. Manuel Zahn
-

3R Pharma Consulting GmbH,
Keltern, GERMANY
Link: www.3rpc.com
Close
|
|
Seminar 1009231
Date: 29.09.2010
-
Your Contact
-

Dr. Henriette Wolf-Klein
Bereichsleiterin Pharma
E-Mail
Close
Venue:
-
Köln
-
Regent Hotel Best Western Premier
Melatengürtel 15 50933 Köln
Tel. +49 221 5499-0 Fax +49 221 5499-998
www.hotelregent.de (new window)
Close
Fee: 890,- EUR zzgl. MwSt.
|
Further Information
-
Aims and Objectives
-
The 7th FORUM Marketing Authorisation conference and seminar focuses on the EU & global challenges for regulatory affairs. The conference on day one addresses the new regulatory documents as well as the challenges for global regulatory submissions.
Has the new Variations Regulation simplified the system?
Did the Paediatrics Regulation achieve its goal?
How will the paediatric sessions be included in the SmPCs according to the new guideline?
What consequences will the Bioequivalence Guideline have for the generics industry?
What are the current challenges for the industry and the agency in terms of global regulatory affairs?
The seminar on day two focuses on the strategical and practical aspects of the planning and performance of a DC or MR procedure. What are delaying and accelerating factors in this field? (Familiarity with the procedures is presumed here.) May we invite you to take part in the discussion with speakers from various agencies and the industry?
Close
2nd Conference Day
|
|
|